Event
CHBE Seminar: Dr. Arun Menawat, Profound Medical
Friday, April 11, 2025
11:00 a.m.
Room 2108 Chemical and Nuclear Engineering Building
Patricia Lorenzana
301-405-1935
plorenza@umd.edu
"The role of medical imaging and autonomous robotics in the future of surgery"
Abstract: Estimates are that over 600 Million medical images are taken every year to diagnose patients within the United States. The question is if medical imaging is so important to diagnose the patient can it also be used by surgeons to treat patients and improve the quality of surgery. Can medical imaging and robotics be combined to create 'incision-free surgery"? Can Star Track surgery become a reality?
Bio: Dr. Arun Menawat is Chairman and CEO of Profound Medical Inc., a commercial-stage medical technology company that markets real-time MRI-guided thermal ultrasound systems for incision-free ablation of abnormal or cancerous tissue. Profound’s key product is the TULSA-PRO therapeutic system, designed for precise and customizable ablation of diseased prostate tissue.
Before joining Profound, Arun served as the President and CEO of Novadaq Technologies Inc. for 13 years, guiding the company from a startup to one of the fastest growing, NASDAQ listed medical technology companies in North America, with a market cap of mostly over one billion USD during the final three years of his leadership. Earlier, Arun served as President of Cedara Software Corp., a company that developed the industry’s first medical imaging software platform. Today, Cedara’s imaging platform and its big data collection are part of IBM’s Watson Health.
He obtained a Ph.D. in Chemical Engineering from the University of Maryland, and an Executive MBA from the J.L. Kellogg School of Management, Northwestern University. In 2014, he was named the EY Ontario Entrepreneur of the Year in the health sciences category.
